Imaging 33 , 13461351 (2006)
Consider working with a trainer initially to learn correct technique and prevent injury
To frame the potential total addressable market (TAM) for GLP-1 medications, we can start with the 800 million people who are estimated to be overweight or obese worldwide
For weight management in patients without diabetes, the situation is more nuanced but current evidence suggests that obesity should also be treated as a chronic condition requiring ongoing management
Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award numbers R41CA240124, R42CA240124, R37CA065910, and P30CA023074
Pfizer has reinvigorated its ambition of competing with Novo Nordisk and Lilly in the lucrative obesity market, striking a $4.9 billion deal to acquire Metsera